发明名称 |
METHODS FOR TREATING RETINOPATHY WITH EXTENDED THERAPEUTIC EFFECT |
摘要 |
Methods for treating and preventing retinopathic conditions by administering an anti-VEGF compound to the vitreous chamber of a patient at risk of, or suffering from, the retinopathy. |
申请公布号 |
US2014328835(A1) |
申请公布日期 |
2014.11.06 |
申请号 |
US201414306363 |
申请日期 |
2014.06.17 |
申请人 |
Allergan, Inc. |
发明人 |
Whitcup Scott M.;Weber David A. |
分类号 |
A61K47/34;A61K39/395;A61K9/00;C07K16/22 |
主分类号 |
A61K47/34 |
代理机构 |
|
代理人 |
|
主权项 |
1. An ocular implant for treating macular degeneration comprising an active agent and a carrier associated with the active agent, wherein the carrier comprises a 30/10 w/w mixture of hydrophilic end PLGA and hydrophobic end PLGA and wherein the active agent is a compound that acts to inhibit formation of VEGF or inhibits the binding of VEGF to its receptor and wherein the ocular implant is formed by an extrusion method. |
地址 |
Irvine CA US |